Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study

BACKGROUND AND AIMS: To assess whether corticosteroids improve prognosis in patients with AS‐AIH, and to identify factors at therapy initiation and during therapy predictive of the response to corticosteroids. METHODS: This was a retrospective cohort study including all patients with AS‐AIH admitted...

Descripción completa

Detalles Bibliográficos
Autores principales: Téllez, Luis, Sánchez Rodríguez, Eugenia, Rodríguez de Santiago, Enrique, Llovet, Laura, Gómez‐Outomuro, Ana, Díaz‐Fontenla, Fernando, Álvarez López, Patricia, García‐Eliz, María, Amaral, Carla, Sánchez‐Torrijos, Yolanda, Fortea, José Ignacio, Ferre‐Aracil, Carlos, Rodríguez‐Perálvarez, Manuel, Abadía, Marta, Gómez‐Camarero, Judith, Olveira, Antonio, Calleja, José Luis, Crespo, Javier, Romero, Manuel, Hernández‐Guerra, Manuel, Berenguer, Marina, Riveiro‐Barciela, Mar, Salcedo, Magdalena, Rodríguez, Manuel, Londoño, María Carlota, Albillos, Agustín, Omella, Ignacio, Trapero, María, Gea, Francisco, Alvarez‐Navascués, Carmen, González‐Diéguez, María‐Luisa, Romero‐Gómez, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Corticosteroids in Autoimmune Hepatitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324977/
https://www.ncbi.nlm.nih.gov/pubmed/35470447
http://dx.doi.org/10.1111/apt.16926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324977/
https://www.ncbi.nlm.nih.gov/pubmed/35470447
http://dx.doi.org/10.1111/apt.16926

Ejemplares similares